A mix of key note speaker presentations, shorter presentations and ample network opportunities will fill up the program with the mission to create a platform for industry and academy to meet and initiate new relationships and collaborations.

Program outline

October 4th  
19.00 – 21.00 Speakers and sponsors executive dinner
Crowne Plaza Copenhagen Towers, Ørestad, Copenhagen S.
Dinner for the speakers, sponsors, and organizing partners
19.00 Registration & Networking
Drinks and starter
19.25 Welcome
Petter Hartman, CEO, Medicon Valley Alliance, Denmark & Sweden
Morten Sommer, Professor, Technical University of Denmark, Denmark
19.30 Main course
20.30 Networking
Coffee and dessert
 October 5th 1-day MVA Microbiome Summit
 Edvard Thomsens Vej 14, Ørestad, Copenhagen S
 8.00 Registration and networking
 8.30 Welcome
Petter Hartman, CEO, Medicon Valley Alliance, Denmark & Sweden
Morten Sommer
, Professor, Technical University of Denmark, Denmark

Session 1: Microbiome & metabolic disease
Key Industry – Novo Nordisk A/S, Denmark

Fredrik Wolfhagen Sand, Senior Scientist, Novo Nordisk A/S, Denmark

Keynote speaker:
Fredrik BäckhedProfessor, University of Gothenburg, Sweden
Mechanistic studies of the impact of the gut microbiome on obesity and type 2 diabetes

Short talks:
Marju Orho-MelanderProfessor, Lund University, Sweden
Population based studies for the role of gut microbiota in metabolic disease
Sandrine ClausAssociate Professor, University of Reading, UK
Metabonomics to inform host-gut microbiota interactions in the context of metabolic diseases
Philip Dubé, Field Applications Scientist, Taconic, USA
Role of the microbiome in a mouse diabetes model

9.50 Coffee break and networking

Session 2: Microbiome & CNS disorders
Key Industry – H. Lundbeck A/S, Denmark

Niels Plath, Vice President, H. Lundbeck A/S, Denmark

Keynote speaker:
John F CryanProfessor, University College Cork, Ireland
Towards Psychobiotics: Microbiome as a Key Regulator of Brain & Behaviour

Short talks:
Frida Fåk Hållenius
Associate Professor, Lund University, Sweden
Role of the gut microbiota in Alzheimer’s disease pathology

Grégoire Chevalier Associate Researcher, Institut Pasteur, France
Microbiota and adult brain plasticity: potential role in depression
Saskia van HemertSenior Scientist, Winclove Probiotics, The Netherlands
Probiotics to treat depressive symptoms?

 11.15 Session 1 and 2: Interactive discussions with audience
 11.45 Lunch, networking and exhibition

Session 3: GI & oral microbiome
Key Industry – Ferring Pharmaceuticals A/S, Denmark

Torsten Reinheimer, Principal Scientist, Ferring Pharmaceuticals A/S, Denmark

Keynote speaker:
Lars EngstrandProfessor, Karolinska Institutet, Sweden
Prospective large-scale studies for characterization of the normal gastro-intestinal microbiome

Short talks:
Ateequr Rehman, Senior Research Scientist, University Kiel, Germany
Microbiome and IBD
William WadeProfessor, Queen Mary University of London, UK
Probiotics for oral diseases?

Shahram LavasaniFounder and CEO, ImmuneBiotech AB
Designed microbiome therapies targeting the microbes and beyond


Session 4: Microbiome, probiotics & nutrition
Key Industry – Probi AB, Sweden

Gunilla Önning, Senior Scientist, Probi AB, Sweden

Keynote speaker:
Mads Fiil Hjorth, Assistant Professor, University of Copenhagen, Denmark
Dietary weight loss depends on gut microbiota composition

Short talks:
Åsa HåkanssonAssociate Senior Lecturer, Lund University, Sweden
Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 suppress ongoing celiac
autoimmunity in children at genetic risk for developing celiac disease
Karen ScottSenior Research Fellow, University of Aberdeen, UK
How different diets affect the gut microbiome

Anita WichmannResearch Scientist, Chr. Hansen A/S
The relevance of mode-of-action research on current probiotics in the microbiome era
– The case for Lactobacillus rhamnosus LGG

 14.50 Coffee break and networking
 15.15 Session 3 and 4: Interactive discussions with audience

Session 5: Microbiome & new technique platforms
Key organisation – Technical University of Denmark, Denmark

Morten Sommer, Professor, Technical University of Denmark, Denmark

Keynote speaker:
H Bjørn NielsenAssociate Professor, Technical University of Denmark
CSO Clinical-Microbiomics, Denmark
Human gut microbes impact host serum metabolome and insulin sensitivity

Short talks:
Gianni PanagiotouAssociate Professor, Leibniz Institute for Natural Product Research and Infection
Biology, Hans Knoell Institute, Germany
Resistant Starch as a Therapeutic Approach of Obesity in Humans: Towards a Mechanistic
Understanding of Gut Microbiome Alterations and Host’s Metabolic Responses

Morten Sommer, Professor, Technical University of Denmark, Denmark
Using cultivation to mine microbiomes? 
Gemma HendersonSenior Scientist, Chr. Hansen A/S
Mining human gut microbial strain collections for next generation probiotics

 16.50 Wrap up, reception and networking
Morten Sommer
, Professor, Technical University of Denmark, Denmark